Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAdcAeGJIbJoy6WWa1cxCGMdGaIeiVLIG_urb8pwCnNeo#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _4 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _4 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _3 provenance.
- assertion hadPrimarySource 18155543 provenance.
- _3 wasQuotedFrom 18155543 provenance.
- _3 value "Treatment of VSMCs with AG-II was observed to induce premature cellular senescence (overexpression of p53/p21) and increase the production of proinflammatory cytokines through nuclear factor-B activation; both effects were neutralized by blocking the p21 pathway.97 The same effects of AG-II were also observed in vivo in a mouse model of atherosclerosis.97" provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.